0000000000223448

AUTHOR

T. Deboli

showing 2 related works from this author

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa

2019

Background: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland–bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays, there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used. Objective: The objective of this study was to demonstrate the validity, reliability and responsiveness of HIDRAdisk, a new innovative t…

MalePsychometricsVisual Analog ScaleIntraclass correlationAcne ‐ RosaceaHIDRAdiskLongitudinal StudieSeverity of Illness Index030207 dermatology & venereal diseases0302 clinical medicineQuality of lifeSurveys and QuestionnairesHidradenitis suppurativa030212 general & internal medicineLongitudinal StudiesIMPACT IMPAIRMENT VALIDITY DISEASE.HIDRAdisk Hidradenitis Suppurativa Quality of Life Validation study Visual toolValidation studyDermatology Life Quality IndexMiddle AgedhumanitiesInfectious DiseasesHIDRAdisk; Hidradenitis Suppurativa; Quality of Life; Validation study; Visual toolItalyhidradenitis suppurativa; visual analog scale; quality of LifeFemaleOriginal ArticleSettore MED/35 - MALATTIE CUTANEE E VENEREEVisual toolPsychometricHumanAdultmedicine.medical_specialtyPsychometricsVisual analogue scaleReproducibility of ResultDermatology03 medical and health sciencesYoung AdultCronbach's alphaInternal medicineSeverity of illnessmedicineHumansbusiness.industryhidradenitis suppurativaReproducibility of Resultsmedicine.diseaseQuality of Lifebusiness
researchProduct

Physician–patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, pros…

2017

Background: Patients with multiple actinic keratoses (AKs) should be treated with field-directed therapy. Such treatments challenge patients’ adherence due to out-of-pocket costs, length of treatment and severity of local skin reactions (LSRs). Effective physician–patient communication (PPC) may buffer therapy-related distress, thus improving quality of life, treatment satisfaction and adherence. Objectives: We evaluated the interplay between PPC, LSR intensity (safety) and lesion clearance rates (effectiveness) on treatment satisfaction, quality of life and treatment adherence among patients with multiple AKs receiving topical field-directed therapies. Methods: In this observational, multi…

Male2708; infectious diseases; actinic keratosesDiclofenacActinictopical field‐directed therapyAnti-Inflammatory AgentsAntineoplastic AgentsAdministration CutaneousMedication AdherenceAdministration Cutaneous; Aged; Aged 80 and over; Anti-Inflammatory Agents Non-Steroidal; Antineoplastic Agents; Diclofenac; Diterpenes; Drug Eruptions; Female; Humans; Imiquimod; Italy; Keratosis Actinic; Longitudinal Studies; Male; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Communication; Medication Adherence; Patient Satisfaction; Physician-Patient Relationsactinic keratoses2708; Infectious Diseases80 and overHumansLongitudinal StudiesPatient Reported Outcome MeasuresProspective Studiesactinic keratoseAgedAged 80 and overPhysician-Patient RelationsImiquimodtreatmentCommunicationAnti-Inflammatory Agents Non-SteroidalKeratosisMiddle AgedKeratosis ActinicInfectious DiseasesCutaneousItalyPatient SatisfactionAdministrationQuality of LifeFemaleDrug EruptionsDiterpenesSettore MED/35 - MALATTIE CUTANEE E VENEREENon-Steroidal2708
researchProduct